Correlation Between Cerevel Therapeutics and Enanta Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cerevel Therapeutics and Enanta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cerevel Therapeutics and Enanta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cerevel Therapeutics Holdings and Enanta Pharmaceuticals, you can compare the effects of market volatilities on Cerevel Therapeutics and Enanta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cerevel Therapeutics with a short position of Enanta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cerevel Therapeutics and Enanta Pharmaceuticals.

Diversification Opportunities for Cerevel Therapeutics and Enanta Pharmaceuticals

0.4

Correlation Coefficient

Cerevel Therapeutics  Enanta Pharmaceuticals

Very weak diversification

The 3 months correlation between Cerevel and Enanta is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Cerevel Therapeutics Holdings and Enanta Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enanta Pharmaceuticals and Cerevel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cerevel Therapeutics Holdings are associated (or correlated) with Enanta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enanta Pharmaceuticals has no effect on the direction of Cerevel Therapeutics i.e., Cerevel Therapeutics and Enanta Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cerevel Therapeutics and Enanta Pharmaceuticals

If you would invest (100.00) in Cerevel Therapeutics Holdings on September 17, 2024 and sell it today you would earn a total of  100.00  from holding Cerevel Therapeutics Holdings or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	0.0%
Values	Daily Returns

Cerevel Therapeutics Holdings  vs.  Enanta Pharmaceuticals

Cerevel Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cerevel Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Cerevel Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Enanta Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enanta Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Cerevel Therapeutics and Enanta Pharmaceuticals

The main advantage of trading using opposite Cerevel Therapeutics and Enanta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cerevel Therapeutics position performs unexpectedly, Enanta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will offset losses from the drop in Enanta Pharmaceuticals' long position.

The idea behind Cerevel Therapeutics Holdings and Enanta Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.